Form 8-K - Current report:
SEC Accession No. 0001640334-19-000661
Filing Date
2019-04-19
Accepted
2019-04-19 17:26:30
Documents
2
Period of Report
2019-04-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K inmb_8k.htm 8-K 12817
2 EX-99.1 inmb_ex991.htm EX-99.1 5917
  Complete submission text file 0001640334-19-000661.txt   19847
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 19758323
SIC: 2836 Biological Products, (No Diagnostic Substances)